"Dose or Strength to be Studied" in ICH M13A [Regulatives / Guidelines]

posted by BEQool  – 2024-10-07 12:33 (276 d 06:18 ago) – Posting: # 24221
Views: 2,171

Hello,

I was wondering the exact same thing but I think that this red text applies just to high-risk products with less than proportional increases in AUC and/or Cmax with increasing dose over the range of strengths proposed (the latter explanation of yours).
Otherwise this would have been written at least in a seperate paragraph as this whole paragraph is talking about less than proportional increases in AUC and/or Cmax with increasing dose.

Regards
BEQool

Complete thread:

UA Flag
Activity
 Admin contact
23,429 posts in 4,930 threads, 1,680 registered users;
51 visitors (0 registered, 51 guests [including 11 identified bots]).
Forum time: 18:52 CEST (Europe/Vienna)

To know that we know what we know,
and to know that we do not know what we do not know,
that is true knowledge.    Nicolaus Copernicus

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5